{"id":21779,"date":"2026-06-15T07:58:20","date_gmt":"2026-06-15T10:58:20","guid":{"rendered":"https:\/\/conexaodjota.com.br\/?p=21779"},"modified":"2026-06-15T07:58:20","modified_gmt":"2026-06-15T10:58:20","slug":"sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide","status":"publish","type":"post","link":"https:\/\/conexaodjota.com.br\/?p=21779","title":{"rendered":"SUS inclui nova terapia para pacientes adultos com leucemia mieloide"},"content":{"rendered":"<\/p>\n<p><a class=\"\" href=\"https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2026-06\/sus-inclui-nova-terapia-para-pacientes-adultos-com-leucemia-mieloide\"><br \/>\n                    <img decoding=\"async\" src=\"https:\/\/cdn.jsdelivr.net\/gh\/sergiosdlima\/assets-ebc@1.0.0\/abr\/assets\/images\/logo-agenciabrasil.svg\" alt=\"Logo Ag\u00eancia Brasil\"><br \/>\n\t\t\t\t<\/a><\/p>\n<p><strong>O Minist\u00e9rio da Sa\u00fade passar\u00e1 a inserir, no <a href=\"https:\/\/www.gov.br\/saude\/pt-br\/sus\" target=\"_blank\">Sistema \u00danico de Sa\u00fade (SUS)<\/a>, o tratamento combinado de venetoclax com azacitidina para pacientes adultos com leucemia mieloide aguda rec\u00e9m-diagnosticada.<\/strong><img decoding=\"async\" src=\"https:\/\/agenciabrasil.ebc.com.br\/ebc.png?id=1693363&#038;o=rss\"><img decoding=\"async\" src=\"https:\/\/agenciabrasil.ebc.com.br\/ebc.gif?id=1693363&#038;o=rss\"><\/p>\n<p>A combina\u00e7\u00e3o dos medicamentos \u00e9 indicada a pacientes que, por condi\u00e7\u00f5es cl\u00ednicas, n\u00e3o s\u00e3o eleg\u00edveis ao tratamento padr\u00e3o com quimioterapia intensiva, sendo mais uma alternativa de terapia\u00a0para esse p\u00fablico.<\/p>\n<\/p>\n<h3>Not\u00edcias relacionadas:<\/h3>\n<ul>\n<li><a href=\"https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2025-09\/estudo-busca-eliminar-transmissao-vertical-de-virus-que-causa-leucemia\">Estudo busca eliminar transmiss\u00e3o vertical de v\u00edrus que causa leucemia.<\/a><\/li>\n<li><a href=\"https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2023-09\/anvisa-autoriza-pesquisa-em-pacientes-com-leucemia-linfoide-aguda-b\">Anvisa autoriza pesquisa em pacientes com leucemia linfoide aguda B.<\/a><\/li>\n<li><a href=\"https:\/\/agenciabrasil.ebc.com.br\/internacional\/noticia\/2022-11\/leucemia-mata-ex-presidente-da-china-jian-zemim\">Leucemia mata ex-presidente da China, Jian Zemim.<\/a><\/li>\n<\/ul>\n<p>De acordo com <a href=\"https:\/\/www.in.gov.br\/en\/web\/dou\/-\/portaria-sctie\/ms-n-30-de-12-de-junho-de-2026-712054830\" target=\"_blank\">Portaria n\u00ba 30\/2026<\/a>, publicada nesta segunda-feira (15), a nova op\u00e7\u00e3o\u00a0ser\u00e1 disponibilizada na rede p\u00fablica de sa\u00fade em 180 dias, conforme prev\u00ea norma federal que regula a incorpora\u00e7\u00e3o de tecnologias no SUS.<\/p>\n<p>A medida segue recomenda\u00e7\u00e3o da Comiss\u00e3o Nacional de Incorpora\u00e7\u00e3o de Tecnologias no Sistema \u00danico de Sa\u00fade (Conitec) e est\u00e1 alinhada ao Protocolo Cl\u00ednico do <a href=\"https:\/\/www.gov.br\/saude\/pt-br\" target=\"_blank\">Minist\u00e9rio da Sa\u00fade<\/a>.<\/p>\n<p><strong>O relat\u00f3rio t\u00e9cnico que embasou a decis\u00e3o ficar\u00e1 dispon\u00edvel para consulta p\u00fablica <a href=\"https:\/\/www.gov.br\/conitec\/pt-br\" target=\"_blank\">no portal da Conitec<\/a>.\u00a0<\/strong><\/p>\n<h2>Leucemia<\/h2>\n<p>Segundo o Minist\u00e9rio da Sa\u00fade, <strong>a leucemia \u00e9 um tipo de c\u00e2ncer sangu\u00edneo originado na medula \u00f3ssea, tecido respons\u00e1vel por produzir gl\u00f3bulos vermelhos, brancos e plaquetas. Quando h\u00e1 alguma muta\u00e7\u00e3o gen\u00e9tica, esses componentes\u00a0podem se transformar em c\u00e9lulas cancer\u00edgenas.<\/strong><\/p>\n<p>Na forma aguda, a doen\u00e7a se torna ainda mais fatal se n\u00e3o tratada de forma precoce. O diagn\u00f3stico nos primeiros est\u00e1gios e o encaminhamento especializado s\u00e3o essenciais para bons resultados do tratamento.\u00a0<\/p>\n<p>Essa \u00e9 a forma mais comum da leucemia aguda em adultos e atinge, principalmente, pacientes idosos.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>O Minist\u00e9rio da Sa\u00fade passar\u00e1 a inserir, no Sistema \u00danico de Sa\u00fade (SUS), o tratamento combinado de venetoclax com azacitidina para pacientes adultos com leucemia mieloide aguda rec\u00e9m-diagnosticada. A combina\u00e7\u00e3o dos medicamentos \u00e9 indicada a pacientes que, por condi\u00e7\u00f5es cl\u00ednicas, n\u00e3o s\u00e3o eleg\u00edveis ao tratamento padr\u00e3o com quimioterapia intensiva, sendo mais uma alternativa de terapia\u00a0para [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":21780,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[46],"tags":[],"class_list":["post-21779","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saude"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/conexaodjota.com.br\/index.php?rest_route=\/wp\/v2\/posts\/21779","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/conexaodjota.com.br\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/conexaodjota.com.br\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/conexaodjota.com.br\/index.php?rest_route=\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/conexaodjota.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=21779"}],"version-history":[{"count":0,"href":"https:\/\/conexaodjota.com.br\/index.php?rest_route=\/wp\/v2\/posts\/21779\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/conexaodjota.com.br\/index.php?rest_route=\/wp\/v2\/media\/21780"}],"wp:attachment":[{"href":"https:\/\/conexaodjota.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=21779"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/conexaodjota.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=21779"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/conexaodjota.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=21779"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}